Comments on: Andrographis paniculata (Kalmegh): Antiviral Clinical Evidence for Colds, Flu, and Beyond

By: Michael Martin

Michael Martin — Tue, 08 Sep 2026 13:54:25 +0000

i'd want a peer-reviewed source for the andrographolide mechanism you described before recommending to patients

Sanjay Mukherjee — Sun, 06 Sep 2026 14:57:11 +0000

the dosage range of 400mg you cited , the quality of supplements varies so much in India. hard to replicate results.

Anjali Sinha — Sat, 05 Sep 2026 10:33:18 +0000

Can someone clarify the dosage range of 400mg you cited? I have a digestive condition.

Priyanka Williams — Wed, 02 Sep 2026 20:23:53 +0000

I liked the practical side of Andrographis paniculata (Kalmegh). This would be easier to follow with a one-week sample plan.

Paul Walker — Mon, 31 Aug 2026 08:00:38 +0000

Just found this via Google, still wondering about the clinical trial for common cold duration reduction.

Shruti Joshi — Tue, 25 Aug 2026 17:30:27 +0000

I liked the practical side of Andrographis paniculata (Kalmegh). This is the kind of detail readers can test slowly.

Mark Chopra — Tue, 18 Aug 2026 15:31:02 +0000

the explanation of the dosage range of 400mg you cited was clear and not oversimplified. appreciated.

Paul Moore — Mon, 17 Aug 2026 19:06:38 +0000

I liked the practical side of Andrographis paniculata (Kalmegh). A few more examples would still help.

Nicole Hall — Sun, 16 Aug 2026 07:32:33 +0000

the explanation of the andrographolide mechanism you described was clear and not oversimplified. appreciated.

Eric Adams — Wed, 29 Jul 2026 14:44:56 +0000

I have kapha prakriti, does the andrographolide mechanism you described still apply for me?